XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Activities    
Net income (loss) attributable to Adient $ 219 $ (186)
Income attributable to noncontrolling interests 48 46
Net income (loss) 267 (140)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:    
Depreciation 139 147
Amortization of intangibles 19 19
Pension and postretirement contributions, net (12) (18)
Equity in earnings of partially-owned affiliates, net of dividends received (includes purchase accounting amortization of $2 and $2, respectively) (139) (103)
(Gain) on sale/impairment of nonconsolidated partially-owned affiliates (33) 216
Premium paid on repurchase of debt 46 0
Deferred income taxes (3) 5
Non-cash impairment charges 10 0
Loss on divestitures - net 0 25
Equity-based compensation 26 1
Other 6 5
Changes in assets and liabilities:    
Receivables (120) 508
Inventories (71) (30)
Other assets (85) 38
Restructuring reserves (95) (33)
Accounts payable and accrued liabilities 135 (466)
Accrued income taxes 50 9
Cash provided (used) by operating activities 140 183
Investing Activities    
Capital expenditures (126) (185)
Sale of property, plant and equipment 12 4
Settlement of cross-currency interest rate swap 0 10
Receipt of deferred consideration 19 0
Changes in long-term investments 0 (37)
Cash provided (used) by investing activities (95) (208)
Financing Activities    
Increase (decrease) in short-term debt 6 818
Repayment of long-term debt (705) (4)
Debt financing costs (1) (1)
Dividends paid to noncontrolling interests (59) (59)
Other (3) (2)
Cash provided (used) by financing activities (762) 752
Effect of exchange rate changes on cash and cash equivalents 12 (11)
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale (705) 716
Change in cash classified within current assets held for sale (3) 0
Increase (decrease) in cash and cash equivalents (708) 716
Cash and cash equivalents at beginning of period 1,692 924
Cash and cash equivalents at end of period $ 984 $ 1,640